AbCellera and Jazz Pharmaceuticals are both companies operating within the biomedical industry.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AbCellera and Jazz Pharmaceuticals are both companies operating within the biomedical industry.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
-
AbCellera
company in Vancouver, Canada
Nothing else this week.
Related events
- Jazz Pharmaceuticals and RYTHM are competing in the pharmaceutical market and listed on the Nasdaq stock exchange.
- Jazz Pharmaceuticals guaranteed notes issued by its subsidiary, Jazz Investments I Limited, on August 26, 2026.
- The California State Teachers Retirement System has increased its stake in Jazz Pharmaceuticals.
- Iambic Therapeutics announced multiple new partnerships, including collaborations with Jazz Pharmaceuticals and AbbVie, and received backing from Qatar Investment Authority and Nvidia.
Coverage
Newest first; wire copies grouped- ZacksStrength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength? AbCellera Biologics Inc. (ABCL) shares rallied 15% in the last trading session to close at $5.15. This move can be